Discuss This Drug

trastuzumab-qyyp

CHEBI:CHEBI_749578

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2472794
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_start_date
20200224
package_marketing_start_date
20200224
route
INTRAVENOUS
marketing_category
BLA
nui
N0000020008
pharm_class_epc
HER2/neu Receptor Antagonist [EPC]
pharm_class
HER2/Neu/cerbB2 Antagonists [MoA]
pharm_class_moa
HER2/Neu/cerbB2 Antagonists [MoA]
labeler_name
Pfizer Laboratories Div Pfizer Inc
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
unii
P188ANX8CK
generic_name
trastuzumab-qyyp
brand_name
Trazimera
brand_name_base
Trazimera
product_ndc
0069-0308
application_number
BLA761081
spl_id
24399684-3818-4410-aecb-32b822817a4b
package_ndc
0069-0308-01
package_description
1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL
spl_set_id
b9c5e894-27d2-4245-a653-df986fed3c56
active_ingredient_name
TRASTUZUMAB
active_ingredient_strength
150 mg/7.15mL
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class